Lantern Pharma Inc. (LTRN) Short Interest
Nasdaq • LTRN • US51654W1018
As of Oct 27, 2026, ORTEX estimated 5.3% of free float sold short, 1.8 days to cover, cost to borrow 3.38%. Sign up for live short interest data.
Nasdaq • LTRN • US51654W1018
As of Oct 27, 2026, ORTEX estimated 5.3% of free float sold short, 1.8 days to cover, cost to borrow 3.38%. Sign up for live short interest data.
This page tracks how heavily Lantern Pharma Inc. (Nasdaq:LTRN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Lantern Pharma Inc. (Nasdaq: LTRN) has a market capitalization of $5.92M. Last close $0.46 (as of 2026-11-11); 52-week range $0.45 to $4.34. ORTEX data as of 2026-10-27: short interest was 5.28% of free float, 1.8 days to cover and the average cost to borrow was 3.38%. Sign up for live short interest data.